HomeHLS • TSE
add
HLS Therapeutics Inc
Previous close
$4.25
Day range
$4.38 - $4.50
Year range
$3.00 - $4.98
Market cap
139.18M CAD
Avg Volume
11.44K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 15.54M | -2.02% |
Operating expense | 11.62M | -10.97% |
Net income | -3.02M | 44.03% |
Net profit margin | -19.45 | 42.88% |
Earnings per share | -0.10 | 41.18% |
EBITDA | 5.09M | -13.38% |
Effective tax rate | -2.89% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.46M | -20.48% |
Total assets | 159.90M | -23.51% |
Total liabilities | 88.56M | -20.47% |
Total equity | 71.34M | — |
Shares outstanding | 31.79M | — |
Price to book | 1.90 | — |
Return on assets | -0.45% | — |
Return on capital | -0.52% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.02M | 44.03% |
Cash from operations | 3.20M | -14.17% |
Cash from investing | -13.00K | 7.14% |
Cash from financing | -2.65M | 31.70% |
Net change in cash | -84.00K | -158.33% |
Free cash flow | 4.29M | -15.88% |
About
Founded
2014
Website
Employees
85
